HK1134781A1 - Feline vaccines against avian influenza - Google Patents

Feline vaccines against avian influenza

Info

Publication number
HK1134781A1
HK1134781A1 HK10101436.8A HK10101436A HK1134781A1 HK 1134781 A1 HK1134781 A1 HK 1134781A1 HK 10101436 A HK10101436 A HK 10101436A HK 1134781 A1 HK1134781 A1 HK 1134781A1
Authority
HK
Hong Kong
Prior art keywords
avian influenza
vaccines against
against avian
feline vaccines
feline
Prior art date
Application number
HK10101436.8A
Other languages
English (en)
Inventor
Kemal Karaca
Jules Maarten Minke
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/557,040 external-priority patent/US7910112B2/en
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of HK1134781A1 publication Critical patent/HK1134781A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24071—Demonstrated in vivo effect
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK10101436.8A 2006-11-06 2010-02-09 Feline vaccines against avian influenza HK1134781A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/557,040 US7910112B2 (en) 2006-11-06 2006-11-06 Feline vaccines against avian influenza
US11/767,276 US20080107687A1 (en) 2006-11-06 2007-06-22 Feline vaccines against avian influenza
PCT/US2007/083648 WO2008058081A1 (fr) 2006-11-06 2007-11-05 Vaccins contre la grippe aviaire pour des félins

Publications (1)

Publication Number Publication Date
HK1134781A1 true HK1134781A1 (en) 2010-05-14

Family

ID=39364854

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10101436.8A HK1134781A1 (en) 2006-11-06 2010-02-09 Feline vaccines against avian influenza

Country Status (9)

Country Link
US (1) US20080107687A1 (fr)
EP (1) EP2091560B1 (fr)
AU (1) AU2007316465B2 (fr)
CA (1) CA2668632C (fr)
DK (1) DK2091560T3 (fr)
HK (1) HK1134781A1 (fr)
NZ (1) NZ576996A (fr)
SI (1) SI2091560T1 (fr)
WO (1) WO2008058081A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652782B2 (en) 2006-09-12 2014-02-18 Longhorn Vaccines & Diagnostics, Llc Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
US9481912B2 (en) 2006-09-12 2016-11-01 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
US8080645B2 (en) 2007-10-01 2011-12-20 Longhorn Vaccines & Diagnostics Llc Biological specimen collection/transport compositions and methods
US8097419B2 (en) 2006-09-12 2012-01-17 Longhorn Vaccines & Diagnostics Llc Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
CA2667454C (fr) 2006-10-25 2015-12-01 Intervet International B.V. Vaccin contre la grippe feline et procede d'utilisation
US9683256B2 (en) 2007-10-01 2017-06-20 Longhorn Vaccines And Diagnostics, Llc Biological specimen collection and transport system
US11041215B2 (en) 2007-08-24 2021-06-22 Longhorn Vaccines And Diagnostics, Llc PCR ready compositions and methods for detecting and identifying nucleic acid sequences
RU2468034C2 (ru) 2007-08-27 2012-11-27 ЛОНГХОРН ВЭКСИНС ЭНД ДИАГНОСТИКС ЭлЭлСи Иммуногенные композиции и способы
US10004799B2 (en) 2007-08-27 2018-06-26 Longhorn Vaccines And Diagnostics, Llc Composite antigenic sequences and vaccines
US11041216B2 (en) 2007-10-01 2021-06-22 Longhorn Vaccines And Diagnostics, Llc Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
CA2861667C (fr) 2007-10-01 2017-06-13 Longhorn Vaccines And Diagnostics, Llc Systeme de prelevement et de transport d'echantillons biologiques et procedes d'utilisation
WO2010063033A2 (fr) 2008-11-28 2010-06-03 Merial Limited Vaccin contre la grippe aviaire recombiné et ses utilisations
US20140205993A1 (en) * 2013-01-18 2014-07-24 Biolex Therapeutics, Inc. Recombinant avian influenza vaccine and uses thereof
US20140205619A1 (en) * 2008-11-28 2014-07-24 Biolex Therapeutics, Inc. Recombinant avian influenza vaccine and uses thereof
US20120003263A1 (en) * 2008-12-05 2012-01-05 Warf - Wisconsin Alumni Research Foundation Recombinant raccoon pox virus vaccine against highly pathogenic avian influenza
EP2998315B2 (fr) 2009-04-03 2021-11-03 Boehringer Ingelheim Animal Health USA Inc. Vaccins aviaires vectorisés par le virus de la maladie de newcastle
CA3207612A1 (fr) 2012-01-26 2013-08-01 Longhorn Vaccines And Diagnostics, Llc Sequences et vaccins antigeniques composites
WO2016183292A1 (fr) 2015-05-14 2016-11-17 Longhorn Vaccines And Diagnostics, Llc Procédés rapides pour l'extraction d'acides nucléiques provenant d'échantillons biologiques

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505941A (en) * 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US6309647B1 (en) * 1999-07-15 2001-10-30 Aventis Pasteur Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants
WO1992015672A1 (fr) * 1991-03-07 1992-09-17 Virogenetics Corporation Souche de vaccin mise au point par genie genetique
US7052831B2 (en) * 2000-09-29 2006-05-30 Becton Dickinson And Company Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device
US20040037848A1 (en) * 2001-04-06 2004-02-26 Audonnet Jean-Christophe Francis Recombinant vaccine against West Nile Virus
UA84024C2 (ru) * 2003-07-24 2008-09-10 Мериал Лимитед Новые вакцинные композиции, которые содержат эмульсию типа "масло в воде"
WO2007047728A2 (fr) * 2005-10-20 2007-04-26 Wyeth Compositions et méthodes pour traiter une virose de la grippe canine

Also Published As

Publication number Publication date
EP2091560B1 (fr) 2014-02-19
US20080107687A1 (en) 2008-05-08
AU2007316465B2 (en) 2013-06-20
WO2008058081A9 (fr) 2013-05-16
CA2668632A1 (fr) 2008-05-15
SI2091560T1 (sl) 2014-05-30
AU2007316465A1 (en) 2008-05-15
CA2668632C (fr) 2016-02-16
EP2091560A4 (fr) 2012-05-30
WO2008058081A1 (fr) 2008-05-15
DK2091560T3 (en) 2014-03-10
EP2091560A1 (fr) 2009-08-26
NZ576996A (en) 2012-03-30

Similar Documents

Publication Publication Date Title
HK1134781A1 (en) Feline vaccines against avian influenza
IL196024A0 (en) Influenza vaccine
HK1143085A1 (en) Low-additive influenza vaccines
PT2043682E (pt) Vacina da influenza
ATE450271T1 (de) Impfstoff
GB0607088D0 (en) Vaccine
SI1942933T1 (sl) Cepiva proti pasji influenci
DK2069503T3 (da) Papayamosaikvirus-baserede vacciner mod influenza
EP1998814A4 (fr) Nouveaux vaccins contre l'influenza m2
ZA200809056B (en) Influenza virus vaccine
ZA200702876B (en) Multivalent avian influenza vaccines
EP2075005A4 (fr) Vaccin de salk (ipv ) et contre la diphtérie, la coqueluche et le tétanos (dpt)
EP2097103A4 (fr) Formulations de vaccin contre l'influenza
EP2368899B8 (fr) Vaccin contre la grippe aviaire
HK1243353A1 (zh) 犬流感疫苗
GB0617602D0 (en) Vaccine
ZA200900062B (en) Influenza vaccine
GB0625453D0 (en) Influenza vaccine
GB0623865D0 (en) Influenza vaccine
GB0618195D0 (en) Influenza vaccine
GB0619090D0 (en) Influenza vaccine
GB0623218D0 (en) Influenza vaccine
IL191977A0 (en) Improved influenza vaccine
GB0607087D0 (en) Vaccine
GB0619820D0 (en) Vaccine

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20191103